These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9584191)

  • 1. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase.
    Srivastava RK; Srivastava AR; Korsmeyer SJ; Nesterova M; Cho-Chung YS; Longo DL
    Mol Cell Biol; 1998 Jun; 18(6):3509-17. PubMed ID: 9584191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review.
    Wang LG; Liu XM; Kreis W; Budman DR
    Cancer Chemother Pharmacol; 1999; 44(5):355-61. PubMed ID: 10501907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
    Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T
    Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
    Ibrado AM; Liu L; Bhalla K
    Cancer Res; 1997 Mar; 57(6):1109-15. PubMed ID: 9067280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl2 is the guardian of microtubule integrity.
    Haldar S; Basu A; Croce CM
    Cancer Res; 1997 Jan; 57(2):229-33. PubMed ID: 9000560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
    Schmitt E; Steyaert A; Cimoli G; Bertrand R
    Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
    Moon EY; Lerner A
    Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in human cancer cells by TZT-1027, an antimicrotubule agent.
    Watanabe J; Natsume T; Fujio N; Miyasaka K; Kobayashi M
    Apoptosis; 2000 Oct; 5(4):345-53. PubMed ID: 11227216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
    Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
    Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells.
    Tan G; Heqing L; Jiangbo C; Ming J; Yanhong M; Xianghe L; Hong S; Li G
    Int J Cancer; 2002 Jan; 97(2):168-72. PubMed ID: 11774260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells.
    Shiah SG; Chuang SE; Kuo ML
    Mol Pharmacol; 2001 Feb; 59(2):254-62. PubMed ID: 11160861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of bax in apoptosis depends on microtubule network mobility.
    Longuet M; Serduc R; Riva C
    Int J Oncol; 2004 Aug; 25(2):309-17. PubMed ID: 15254727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents.
    Gibson S; Widmann C; Johnson GL
    J Biol Chem; 1999 Apr; 274(16):10916-22. PubMed ID: 10196170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells.
    Shtil AA; Mandlekar S; Yu R; Walter RJ; Hagen K; Tan TH; Roninson IB; Kong AN
    Oncogene; 1999 Jan; 18(2):377-84. PubMed ID: 9927194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells.
    Blagosklonny MV; Chuman Y; Bergan RC; Fojo T
    Leukemia; 1999 Jul; 13(7):1028-36. PubMed ID: 10400418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
    Ibrado AM; Huang Y; Fang G; Bhalla K
    Cell Growth Differ; 1996 Aug; 7(8):1087-94. PubMed ID: 8853905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein.
    Basu A; Haldar S
    Int J Oncol; 1998 Oct; 13(4):659-64. PubMed ID: 9735392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.